The end of the physical therapy honor system

The central problem in physical therapy is not the prescription of exercises, but the execution of them. When a patient leaves the clinic with a resistance band, the physiotherapist loses all visibility into the recovery process. Traditional platforms rely on patient self-reporting, a method that is notoriously inaccurate. Patients often overestimate their adherence or mismanage the tempo and intensity required for clinical benefit. Bandcizer is a Danish medtech company that addresses this visibility gap through a patented sensor system that turns standard resistance bands into data-generating instruments.

Founded in 2014 by Anders S. Sørensen and Tim Bang in Roskilde, Denmark, the company spent its first decade focused on clinical validation. The core technology is a capacitive measurement sensor that clips onto any flat resistance band. Unlike camera-based systems that use computer vision to estimate motion, Bandcizer measures the physical tension and elongation of the band itself. This provides a direct record of work performed, repetitions completed, and the specific tempo of each movement. To date, the sensor is the primary measurement tool in 12 peer-reviewed clinical studies across universities in Denmark and Australia.

Moving from motion estimation to tension measurement

The hardware is a two-part magnetic unit that snaps onto the band. It connects to a mobile application that guides the patient through their prescribed program with real-time feedback. This feedback is critical because it forces the patient to maintain the prescribed "time under tension," which is often the first variable sacrificed during unsupervised home training. Clinical data suggests that patients relying on memory alone often cut their time under tension by as much as 47% while believing they are fully compliant.

After a period of quiet development and a recent software rebuild, Bandcizer has shifted toward a more integrated clinical workflow. The platform now includes a clinical dashboard where therapists can review objective compliance data for their entire patient roster. It also features a built-in messaging system, allowing therapists to intervene when the data shows a patient is struggling or skipping sessions. By keeping the messaging and data on the same screen, the company intends to reduce the administrative overhead associated with managing remote recovery.

A rental model for clinical scale

Bandcizer distinguishes itself from the broader healthcare SaaS market through its pricing structure. While competitors like Physitrack typically charge a subscription fee per practitioner, Bandcizer charges 39 EUR per sensor per month. This rental model includes the hardware, the software platform, and unlimited patient accounts. It is a strategic move to encourage adoption across entire clinical teams without increasing headcount-related costs.

This approach shifts the sensor from a piece of capital equipment into a revolving clinical tool. When a patient completes their program, the sensor is returned, cleaned, and assigned to a new patient. The company handles hardware maintenance and replacements as part of the monthly fee, lowering the barrier for smaller clinics to implement objective monitoring. This model reflects a broader shift in medtech: moving away from selling a device toward selling a verifiable outcome.